Try searching for...

      Dr Tim Wang
      /content/dam/genesiscare/headshots/au-doctor-headshots/AU_Oncology_Headshot_GA_ProfTim Wang.jpg
      Radiation Oncologist

      A/Prof Tim Wang

      A/Prof Tim Wang
      A/Prof
      Tim
      Wang

      MBBS, MPH, FRANZCR

      For patients/carers

      For doctors

      MBBS, MPH, FRANZCR

      Locations

      NSW:Bella Vista (Norwest)
      Bella Vista (Norwest), NSW
      Bella Vista (Norwest)
      Level 3, Suite 311, 8 Elizabeth MacArthur Drive, Bella Vista, NSW, 2153, Australia
      -33.74420414961466, 150.95193295767038
      /au/our-centres/nsw-bella-vista-norwest
      NSW

      Languages

      Fluent

      • English
      • Mandarin / 普通话

      Biography

      Clinical interests in breast cancer, melanoma, liver malignancies, and upper gastrointestinal (GI) malignancies.

      Dr Tim (Wei) Wang is a senior radiation oncologist with subspecialty interest including the management of breast cancer, melanoma, liver tumours and upper GI cancer. He has a clinical interest in radiation treatment techniques, and the interaction of radiation therapy with modern systemic therapies. He is the trial chairperson of several ongoing collaborative group clinical trials. Dr Wang is a Clinical Senior Lecturer for the University of Sydney since 2011.

      More information

      Professional memberships
      • RANZCR
      • TROG
      • AGITG
      • MSCT
      • ANZBCTG
      Publications
      • R. Mercieca-Bebber, E. H. Barnes, K. Wilson, Z. Samoon, E. Walpole, T. Mai, S. Ackland, M. Burge, G. Dickie, D. Watson, J. Leung, T. Wang, R. Bohmer, D. Cameron, J. Simes, V. Gebski, M. Smithers, J. Thomas, J. Zalcberg & A. P. Barbour. Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma. BMC Cancer (2022) DOI:10.1186/s12885-022-09270-4
      • Siujoon Choi, Angela Hong, Tim Wang, Seringe Lo, Bi Chen, Ines Silva, Rony Kapoor, Edward Hsiao, Gerald B Fogarty, Matteo S Carlino, Alexander M Menzies, Georgina V Long, Brindha S Shivalingam. Risk of radiation necrosis after stereotactic radiosurgery for melanoma brain metastasis by anatomical location. Strahlenther Onkol (2021)
      • Phuong Dinh, J. Dinny Graham, Elisabeth N. Elder, Masrura Kabir, Tram B. Doan, James French, Farid Meybodi, Rina Hui, Nicholas R. Wilcken, Paul R. Harnett, Jeremy Hsu, Kirsty E. Stuart, Tim Wang, Verity Ahern, Meagan Brennan, Stephen B. Fox, Rachel F. Dear, Elgene Lim, Michelle White, G. Bruce Mann, Nirmala Pathmanathan. Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor positive early breast cancer patients: benefits of physician selective testing. Breast Cancer Research and Treatment (2021)
      • Elissa J Zhang, Kirsty Stuart, Rina Hui, Wei Wang, Verity Ahern, Farid Meybodi, James French, Elisabeth Elder, ME Brennan. Management of early breast cancer at an Australian NSW cancer centre during the early phase of COVID-19 pandemic. Archives of Breast Cancer (2021)
      • Cora Waldstein, Trevor Moodie, Simon Ashworth, Verity Ahern, Kirsty Stuart, Wei Wang. Feasibility of arm-draining lymph node-sparing radiotherapy of breast cancer: A pilot planning study. Journal of medical imaging and radiation oncology (2021)
      • Wei Wang, Jessica Louise Smith, Matteo Salvatore Carlino, Bryan Burmeister, Mark Blayne Pinkham, Gerald Blaise Fogarty, David Robert Harry Christie, Vanessa Estall, Mark Shackleton, Arthur Clements, Rory Wolfe, Le Thi Phuong Thao, Elizabeth Jane Paton, Victoria Steel, Narelle Catherine Williams. Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma. Clinical and translational radiation oncology (2021)

      This GenesisCare practitioner is a shareholder of GenesisCare Australia Holdings Pty Ltd and therefore has a pecuniary interest in GenesisCare as defined by Section 19 of the Private Health Facilities Regulation 2017 (NSW).